Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 2.
doi: 10.1002/lary.70002. Online ahead of print.

Epidemiologic Assessment and Quality of Life Impact of Sinonasal Disease in Cleft Lip and Palate

Affiliations

Epidemiologic Assessment and Quality of Life Impact of Sinonasal Disease in Cleft Lip and Palate

Grace Anne Longfellow et al. Laryngoscope. .

Abstract

Objective: To characterize the prevalence, clinical manifestations, and risk factors of sinonasal pathology in patients with cleft lip and/or palate (CL/P).

Methods: This prospective cohort study included patients aged ≥ 12 years with a history of CL/P, seen at a tertiary craniofacial center from May 2024 to February 2025. Participants completed the Sino-Nasal Outcome Test-22 (SNOT-22) and the Nasal Obstruction Symptom Evaluation (NOSE), assessing sinonasal symptoms. Clinical and demographic data were collected via chart review. Primary outcomes were normalized SNOT-22 and NOSE scores. Statistical analyses included paired and independent t-tests, Pearson correlation, and linear regression to evaluate associations with scores, Veau classification, and age.

Results: Ninety patients were included. Most (83.3%) had non-syndromic CL/P. Chronic rhinosinusitis and allergic rhinitis were reported by 12.2% and 21.1% of participants, respectively. Despite these rates, current sinonasal medication use was high (36.7%). Otolaryngology referrals for sinonasal symptoms were documented in only 21.1% of cases. NOSE scores were significantly higher than SNOT-22 scores (t = -3.65, p < 0.001). After excluding nasal obstruction items in SNOT-22, and quality of life items from both surveys, NOSE scores remained significantly higher (t = -4.65, p < 0.001). No significant differences in total SNOT-22 scores were found across Veau classifications (p = 0.406) or with age (Pearson's r = 0.123, p = 0.250).

Conclusions: Patients with CL/P experience clinically meaningful sinonasal symptoms, predominantly nasal obstruction. Medication use exceeded sinonasal diagnoses, suggesting a higher prevalence of subclinical disease. Incorporating patient-reported outcome measures is essential to uncover the burden of sinonasal pathology and guide multidisciplinary management.

Level of evidence: II.

Keywords: NOSE scale; SNOT‐22; cleft lip and palate (CL/P); sinonasal disease; sinusitis.

PubMed Disclaimer

References

    1. P. A. Mossey, J. Little, R. G. Munger, M. J. Dixon, and W. C. Shaw, “Cleft Lip and Palate,” Lancet 374, no. 9703 (2009): 1773–1785, https://doi.org/10.1016/S0140‐6736(09)60695‐4.
    1. T. Vyas, P. Gupta, S. Kumar, R. Gupta, T. Gupta, and H. Singh, “Cleft of Lip and Palate: A Review,” Journal of Family Medicine and Primary Care 9, no. 6 (2020): 2621–2625, https://doi.org/10.4103/jfmpc.jfmpc_472_20.
    1. R. S. Zhang, L. O. Lin, I. C. Hoppe, et al., “Nasal Obstruction in Children With Cleft Lip and Palate: Results of a Cross‐Sectional Study Utilizing the NOSE Scale,” Cleft Palate Craniofacial Journal 56, no. 2 (2019): 177–186, https://doi.org/10.1177/1055665618772400.
    1. H. Chiang, R. Shah, C. Washabaugh, and D. O. Frank‐Ito, “Nasal Airway Obstruction in Patients With Cleft Lip Nasal Deformity: A Systematic Review,” Journal of Plastic, Reconstructive & Aesthetic Surgery 92 (2024): 48–60, https://doi.org/10.1016/j.bjps.2024.02.061.
    1. A. R. Sedaghat, E. C. Kuan, and G. K. Scadding, “Epidemiology of Chronic Rhinosinusitis: Prevalence and Risk Factors,” Journal of Allergy and Clinical Immunology: In Practice 10, no. 6 (2022): 1395–1403, https://doi.org/10.1016/j.jaip.2022.01.016.

LinkOut - more resources